Live Roundups Editor's Desk Insights Executive Ops Weather About 🔍
Home › Science › SpaceX IPO Is About Buying Elon Musk, Ives Says
Science

SpaceX IPO Is About Buying Elon Musk, Ives Says

SpaceX IPO Is About Buying Elon Musk, Ives Says
Bloomberg Technology Wednesday 03 June 2026, 12:37 UTC 1 min read
SpaceX IPO (ORG) Buying Elon Musk (PERSON) Ives (ORG)
Originally published by Bloomberg Technology Read original →

Related Stories

Jeffery Lee breathes ‘sigh of relief’ after Alabama’s nitrogen execution deemed unconstitutional

A death row prisoner whose planned execution on Thursday was suddenly halted became emotional when he learned that a federal court had ruled Alabama’s use of nitrogen gas violates the constitutional ban on cruel and unusual punishment. “It’s like an expected sigh of relief in one aspect, and then you still got to stay and maintain your focus and continue to fight,” Jeffery Lee, who has been on death row for nearly three decades, told NBC News by phone Tuesday. He spoke from the William C....

NBC News 26m ago

Nearly Everyone, Everywhere, Veers Left When Walking

Researchers are at a loss for why people across cultures and ages, regardless of their dominant hand, have a natural bias toward wandering in a counterclockwise direction.

NYT Science 34m ago

Popular UK seaside town hotel plunges into administration as holidaymakers updated

Popular UK seaside town hotel plunges into administration as holidaymakers updated This popular hotel has entered administration after closing for refurbishment in 2022 A long-shuttered seaside hotel in south Devon, which had been expected to welcome guests again following a major refurbishment, has reportedly gone into administration. According to a notice published by The Gazette, the UK's official public record, administrators were appointed on June 5.

Daily Mirror 46m ago

Scientists were excited about a blood test for many cancers — but it failed a big trial. Here's what to know.

Scientists were excited about a blood test for many cancers — but it failed a big trial. Emerging tests promise to screen for many cancers at once, but one just failed in a big trial. Will these diagnostics deliver on their promise someday?

Live Science 1h ago